| Literature DB >> 2173160 |
R Hawliczek1, P Grunert, H Ferraz-Leite, F Alesch.
Abstract
Methods of stereotactic target localisation are used in brachytherapy of brain tumors for many years. Since 1987 eight patients with inoperable astrocytomas grade I to III were treated at the Neurosurgical Clinic and Clinic for Radiotherapy of the University Vienna by permanent stereotactic I125-seed implantation. For that purpose a newly developed applicator was used. Preliminary results confine the low risk of operation, but the follow-up time is too short for evaluation of the treatment success. Principal problems of brain brachytherapy are discussed in the light of international data. In general, I125 brachytherapy is a useful and well tolerated way of treatment of low grade astrocytomas, the risk is low, which is especially important for children and old patients.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2173160
Source DB: PubMed Journal: Strahlenther Onkol ISSN: 0179-7158 Impact factor: 3.621